Loading...
•
Dec 31, 2025
Doximity Q3 2026 Earnings Report
Doximity reported solid revenue growth and strong profitability with high margins.
Key Takeaways
Doximity delivered double-digit revenue growth in fiscal Q3 2026, generating strong net income and adjusted EBITDA margins while continuing to produce robust cash flow.
Revenue increased 10% year over year to $185.1 million
Net income remained strong with a 33% margin
Adjusted EBITDA margin stayed above 60%
Operating and free cash flow remained solid despite higher investments
Forward Guidance
Management guided for continued profitability and stable margins into the next quarter and full fiscal year.
Positive Outlook
- Continued strong engagement from medical professionals
- High adjusted EBITDA margin outlook
- Strong balance sheet with significant liquidity
- Ongoing share repurchase authorization
- Growing contribution from AI-powered products
Challenges Ahead
- Macroeconomic uncertainty impacting customer budgets
- Potential variability in advertising spend
- Higher investment in product development
- Stock-based compensation remains elevated
- Competitive digital health landscape
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...